InvestorsHub Logo
Followers 15
Posts 2103
Boards Moderated 0
Alias Born 07/01/2016

Re: None

Wednesday, 08/29/2018 1:36:24 PM

Wednesday, August 29, 2018 1:36:24 PM

Post# of 73636
This is Premier Biomedical Inc . today:

http://www.premierbiomedical.com/
https://painreliefmeds.com/

http://www.thestreetnow.com/spotlight/biei/

Twitter
https://twitter.com/PremierBiomedic
https://twitter.com/bieiotc?lang=de

facebook
https://www.facebook.com/Premier-Biomedical-Pain-Relief-Meds-332858840514123/

1.

8 hemp oil / CBD based pain relief products:

First revenues after initial delays:
http://www.premierbiomedical.com/premier-biomedical-ceo-update-letter-july-2018/

Sale among others here:
https://painreliefmeds.com/shop/
https://www.healthwarehouse.com/solr/result/?q=Premier+Biomedical

2.

Patent-pending anti-aging process utilizing Premier Biomedical’s patented process to remove the physiologic basis of aging:

http://www.premierbiomedical.com/anti-aging-patent-application-filed-exclusive-commercial-rights-to-premier-biomedical-inc/

3.

Patent-pending anti-breast cancer drug that outperformed chemo and the leading competitive breast cancer drug in animal tests

4.

Patented process to treat and cure PTSD/ Chronic Traumatic Encephalopathy (CTE)

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139303411
The firm has exceptional privileges to three dispensed patents, one provisional patent application and six pending applications, all related to unique treatments for cancer as well as extracorporeal treatments for different life-threatening ailments.

Research programme: extracorporeal antibody therapies - Premier Biomedical
https://adisinsight.springer.com/drugs/800039542

Research programme: low dose naltrexone-based therapeutic - Premier Biomedical
https://adisinsight.springer.com/drugs/800039614


Further information:

Overview, Quote, Company Profile, Security Details, News, Financials, Disclosure
https://www.otcmarkets.com/stock/BIEI/research

Newsroom
http://www.premierbiomedical.com/newsroom/

CEO UPDATE LETTER (every quarter of a year) — JULY, 2018
http://www.premierbiomedical.com/premier-biomedical-ceo-update-letter-july-2018/

Videos
vimeo Premier Biomedical Inc.
https://www.google.de/search?ei=rhODW9_SE8zLwAL9sbTAAQ&q=vimeo+Premier+Biomedical+Inc.&oq=vimeo+Premier+Biomedical+Inc.&gs_l=psy-ab.12...28148.29838.0.31936.2.2.0.0.0.0.82.144.2.2.0....0...1.1j2.64.psy-ab..0.0.0....0.D5n6B9HJo_k
youtube Premier Biomedical Inc.


Interviews
MONEY TV – last
https://vimeo.com/286450462
Uptick Newswire’s “Stock Day” – last
http://upticknewswire.com/featured-interview-ceo-william-hartman-of-premier-biomedical-inc-otcqb-biei-9/

Press


Intellectual property – patents
http://www.premierbiomedical.com/science/intellectual-property/

Cancer
About the Disease
Conventional Method of Treatment
The Premier Biomedical, Inc. Solution
http://www.premierbiomedical.com/science/cancer/

Blood Sepsis and Viremia
About the Disease
Conventional Method of Treatment
The Premier Biomedical, Inc. Solution
http://www.premierbiomedical.com/science/blood-sepsis-and-viremia/

Fibromyalgia
About the Disease
Conventional Method of Treatment
The Premier Biomedical, Inc. Solution
http://www.premierbiomedical.com/science/fibromyalgia/

Multiple Sclerosis (MS)
About the Disease
Conventional Method of Treatment
The Premier Biomedical, Inc. Solution
http://www.premierbiomedical.com/science/multiple-sclerosis-ms/


Contact
Send all correspondence to our business office:
PO Box 25
Jackson Center, PA 16133
Phone :
(724) 633-7033
(PBI) MED-7033
Email : info@premierbiomedical.com